Form 4: Core Laboratories Inc. /DE/ Executive Reports Stock Transact
Insider Transaction (Form 4)
Mark Damian Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc. /DE/, reported multiple transactions in common stock on October 1, 2026.
Summary
- Tax/exercise-price withholding: disposed of 276 Common Stock at $9.76 ($2,694) on October 1, 2026; holds 28,089 after (Direct).
- Option exercise/conversion: acquired 700 Common Stock on October 1, 2026; holds 28,365 after (Direct).
- Option exercise/conversion: disposed of 700 Restricted Shares on October 1, 2026; holds 250 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Damian Tattoli — Officer (SVP, Gen Counsel & Secretary)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Tax/exercise-price withholding | Common Stock | 276 | $10 | $2.7K | 28,088.621 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 700 | — | — | 28,364.621 |
| 2026-10-01 | Option exercise/conversion | Restricted Shares | 700 | — | — | 250 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Tax/exercise-price withholding (276 shares) |
| 2026-10-01 | Option exercise/conversion (700 shares) |
| 2026-10-01 | Option exercise/conversion (700 shares) |
Keywords
insider transaction, Form 4, CLB, Core Laboratories Inc. /DE/, neutral, Mark Damian Tattoli
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.